Lv41
740 积分 2024-09-01 加入
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
8分钟前
求助中
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
2天前
已完结
Cancer cell therapies: global clinical trial trends and emerging directions
7天前
已完结
Study of the dynamic changes in the non-volatile chemical constituents of black tea during fermentation processing by a non-targeted metabolomics approach
9天前
已完结
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study
15天前
已完结
In vivo CAR T-cell generation in non-human primates using lentiviral vectors displaying a multi-domain fusion ligand
16天前
已完结
Antigen identification and high-throughput interaction mapping by reprogramming viral entry
27天前
已完结
CAR T cell persistence in cancer
29天前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
1个月前
已完结
B cell maturation antigen is a novel target for immunotherapy of acute myeloid leukemia
1个月前
已完结
皖公网安备34019202002308
